Company · DBD
Diebold Nixdorf Incorporated
Name as listed on its exchange; filed with the SEC as DIEBOLD NIXDORF, Inc.
Nasdaq's symbol directory lists DBD on the New York Stock Exchange as “Diebold Nixdorf Incorporated Common stock”.
In the 12 months to Nov 8, 2026: insiders bought on 1 occasion ($51K); insiders sold on 5 occasions ($41.2M); 2 filings by holders of 5% or more; 1 company report (Form 8-K, since May 26, 2026).
Insider trades · SEC Form 4
Those inside the hall
Open-market purchases and sales only. Legs one person filed for one day are combined.
Who traded
- Millstreet Capital Management LLC sold $41.2M
- Thomas S. Timko, EVP, CFO bought $51K
Every trade (6)
- BUYThomas S. Timko, EVP, CFO bought $51K
- SELLMillstreet Capital Management LLC sold $8.5M
- SELLMillstreet Capital Management LLC sold $233K
- SELLMillstreet Capital Management LLC sold $19.2M
- SELLMillstreet Capital Management LLC sold $148K
- SELLMillstreet Capital Management LLC sold $13.1M
Large holders · SEC Schedules 13D and 13G
Five percent and over
Anyone who comes to hold more than 5% of a company's voting shares must tell the SEC. A Schedule 13D is filed by a holder who may seek to influence the company; a 13G by one who states it is a passive investor. An amendment updates an earlier filing, and a stake reported as 0% means the holder says it has sold all, or nearly all, of its shares. Every recent 13D and 13G
- Capital World Investors 34.9%
- Millstreet Capital Management LLC 12.14%
Company reports · SEC Form 8-K
In its own words
Current reports the company filed with the SEC; most items are due within four business days of the event. Each line lists the report's items by the SEC's own titles; the filing says what happened. Reports collected since May 26, 2026; every 8-K at the SEC.
- Results of operations and financial condition Oct 28, 2026
Sources: SEC EDGAR (Forms 4, 144 and 8-K) and STOCK Act periodic transaction reports. Filings can be late, amended or wrong at the source; see methodology.